Effect of a multidisciplinary in-patient rehabilitation program for patients with ankylosing spondylitis: a randomised controlled trial
Not Applicable
Completed
- Conditions
- Ankylosing spondylitis (AS)Musculoskeletal DiseasesAnkylosing spondylitis
- Registration Number
- ISRCTN75685576
- Lead Sponsor
- The Norwegian Government (Helse Øst)
- Brief Summary
2013 results in: https://www.ncbi.nlm.nih.gov/pubmed/23138412 (added 03/05/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 95
Inclusion Criteria
1. Aged between 18 and 65 years
2. AS according to the New York classification criteria
3. Ability to communicate in Norwegian
Exclusion Criteria
1. Coronary heart disease
2. Surgery or rehabilitation last six months
3. Cognitive impairment or mental disease
4. Pregnancy
5. Change in medication last month
6. BASDAI score <40 mm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Physical function, measured by the Bath ankylosing spondylitis functional index (BASFI)<br> 2. Pain, stiffness, fatigue and disease activity: Bath ankylosing spondylitis disease activity index (BASDAI)<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Self-efficacy: the Arthritis Self-Efficacy Scale (ASES)<br> 2. General health: the Short Form-36 and the BAS Patient Global Score (BAS-G)3. Joint mobility: BAS Metrology Index (BASMI)<br> 4. Biological signs of inflammation: erythrocyte sedimentation rate and C-reactive protein<br> 5. Activity and participation: the Canadian Occupational Performance Measure (COPM)<br> 6. Sleep quality: the Pittsburgh Sleep Quality Index<br> 7. Fatigue: BASDAI, SF-36 (vitality scale) and the Multidimensional Fatigue Inventory<br> 8. Use of medications and health care resources<br>